Biblio
Export 1190 results:
Author [ Title] Type Year Filters: First Letter Of Last Name is D [Clear All Filters]
“Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data.”, J Alzheimers Dis, vol. 58, no. 2, pp. 361-371, 2017.
, “Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 58, no. 1, pp. 163-170, 2017.
, “Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.”, J Alzheimers Dis, 2018.
, “Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis.”, J Alzheimers Dis, vol. 88, no. 1, pp. 229-239, 2022.
, “Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer's Disease Detected Using Quantitative Electroencephalography.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1229-1244, 2017.
, “Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing Database.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1503-13, 2016.
, “Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
, “Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 391-405, 2020.
, “Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S299-S312, 2018.
, “Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 87, no. 1, pp. 51-81, 2022.
, “Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies.”, J Alzheimers Dis, vol. 66, no. 2, pp. 587-600, 2018.
, “Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1427-1448, 2023.
, “Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management.”, J Alzheimers Dis, vol. 86, no. 3, pp. 983-999, 2022.
, “Post Traumatic Stress Disorder Heralding the Onset of Semantic Frontotemporal Dementia.”, J Alzheimers Dis, vol. 63, no. 1, pp. 203-215, 2018.
, “Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis.”, J Alzheimers Dis, vol. 66, no. 1, pp. 25-36, 2018.
, “Porphyromonas gingivalis (W83) Infection Induces Alzheimer's Disease-Like Pathophysiology in Obese and Diabetic Mice.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1259-1275, 2021.
, “Porphyromonas gingivalis (W83) Infection Induces Alzheimer's Disease-Like Pathophysiology in Obese and Diabetic Mice.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1259-1275, 2021.
, “Polymorphonuclear Neutrophil Functions are Differentially Altered in Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 60, no. 1, pp. 23-42, 2017.
, “Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels.”, J Alzheimers Dis, vol. 60, no. 3, pp. 769-781, 2017.
, “Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1245-1254, 2017.
, “Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1641-1652, 2017.
, “Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1483-1492, 2022.
, “Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
, “Plasma EFEMP1 Is Associated with Brain Aging and Dementia: The Framingham Heart Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1657-1666, 2021.
, “Plasma Cholesterol Levels as Potential Nutritional Biomarkers for Lewy Body Dementia.”, J Alzheimers Dis, vol. 86, no. 2, pp. 779-786, 2022.
,